NOX4, Mitochondria and Related Biomarkers in Autosomal Dominant Polycystic Kidney Disease
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
To determine the value of NOX4, markers of mitochondria injury and function, and oxidative stress as real-time biomarkers to assess disease severity in patients with early autosomal dominant polycystic kidney disease (ADPKD).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 15
Maximum Age: 40
View:
• ADPKD (based on Ravine et al. criteria)
• Class 1 A-E according to imaging classification
• Male and female subjects 15 - 40 years of age
• Estimated GFR\> 70 mL/min/1.73 m2 (CKD-EPI)
• Ability to provide written, informed consent
Locations
United States
Minnesota
Mayo Clinic
RECRUITING
Rochester
Time Frame
Start Date: 2020-07-21
Estimated Completion Date: 2026-03
Participants
Target number of participants: 60
Treatments
Patients with a previous diagnosis of ADPKD
Patients that have been diagnosed with ADPKD and are classified as Class 1A, 1B, 1C, 1D and 1E.
Authors
Maria V Irazabal
Related Therapeutic Areas
Sponsors
Leads: Mayo Clinic
Collaborators: Polycystic Kidney Disease Foundation